Credit Acceptance Corporation (CACC)

Revance Therapeutics Market Cap

Credit Acceptance has a market cap or net worth of $5.23 billion as of August 6, 2025. Its market cap has decreased by -24.16% in one year.

• Market Cap: 5.23B
• Enterprise Value: 11.63B
• 1-Year Change: -24.16%
• Ranking: #1261
• Category: Mid-Cap
• Stock Price: $465.10

Market Cap Chart

Since December 1, 1998, Credit Acceptance's market cap has increased from $323.90M to $5.23B, an increase of 1,513.66%. That is a compound annual growth rate of 10.98%.

Market Cap History

Date	Market Cap	% Change
Aug 6, 2025	5.23B	-8.08%
Dec 31, 2024	5.69B	-15.06%
Dec 29, 2023	6.69B	9.18%
Dec 30, 2022	6.13B	-38.68%
Dec 31, 2021	10.00B	63.66%
Dec 31, 2020	6.11B	-26.52%
Dec 31, 2019	8.31B	12.79%
Dec 31, 2018	7.37B	18.01%
Dec 29, 2017	6.25B	41.27%
Dec 30, 2016	4.42B	0.30%
Dec 31, 2015	4.41B	56.89%
Dec 31, 2014	2.81B	-5.88%
Dec 31, 2013	2.99B	19.58%
Dec 31, 2012	2.50B	18.21%
Dec 30, 2011	2.11B	23.95%
Dec 31, 2010	1.70B	30.61%
Dec 31, 2009	1.30B	211.46%
Dec 31, 2008	418.80M	-32.93%
Dec 31, 2007	624.40M	-37.76%
Dec 29, 2006	1.00B	69.29%
Dec 30, 2005	592.60M	-36.74%
Dec 31, 2004	936.80M	45.71%
Dec 31, 2003	642.90M	137.76%
Dec 31, 2002	270.40M	-27.78%
Dec 31, 2001	374.40M	46.77%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Berkshire Hathaway	992.50B
JPMorgan Chase & Co.	801.18B
Visa Inc.	650.09B
Mastercard	511.71B
Bank of America	337.46B
Wells Fargo & Company	251.06B
Morgan Stanley	224.22B
HSBC Holdings	213.32B